Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2010European Cardiology ReviewOpen Access

Blood Pressure Lowering for the Prevention of Stroke Recurrence

View Full Paper
Ask AI
Bookmark
Share

Key result

Blood-pressure-lowering treatment reduced the risk of stroke recurrence by 22% (p=0.0007) compared with no treatment or placebo in patients with previous cerebrovascular disease.

Why the study?

Does blood-pressure-lowering treatment reduce stroke recurrence in patients with previous cerebrovascular disease?

Population

Patients with previous cerebrovascular disease (meta-analysis of 10 trials)

Comparison

Blood-pressure-lowering treatment vs No treatment or placebo

Design

Meta-analysis

Authors

ZWZengwu WangPreventive CardiologyTRTom RichartPreventive CardiologyYJYu JinUniversity of Glasgow

Discussion

Loading...

Member takes

Implication

Supports routine BP lowering for secondary stroke prevention; reinforces meta-analytic evidence and extends to diuretic regimen preference.

Study Design

Type

Meta-Analysis

Structured PICO

Does blood-pressure-lowering treatment reduce stroke recurrence in patients with previous cerebrovascular disease?

P
Population
Meta-analysis of 10 trials evaluating patients with previous cerebrovascular disease.
I
Intervention
Blood-pressure-lowering treatment (including regimens with diuretics or renin system inhibitors)
C
Comparator
No treatment or placebo
O
Outcome
Stroke recurrencehard clinical

Main Result

Effect estimate: 22% reduction

p-value: p=0.0007

Blood pressure lowering significantly reduces stroke recurrence, with diuretic-based regimens appearing more effective than renin system inhibitors, likely due to greater blood pressure reduction.

Cite This Study

Wang et al. (2010) conducted a meta-analysis in previous cerebrovascular disease. Blood-pressure-lowering treatment vs. no treatment or placebo was evaluated on stroke recurrence (22% reduction, p=0.0007). Blood-pressure-lowering treatment reduced the risk of stroke recurrence by 22% (p=0.0007) compared with no treatment or placebo in patients with previous cerebrovascular disease.

synapsesocial.com/papers/6a93d0dabbea1c735e92bcd4https://doi.org/10.15420/ecr.2010.6.1.37
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients2005 · 87 citations